Lv42
438 积分 2025-01-15 加入
Ecnoglutide: First Approvals
16天前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
18天前
已完结
Mazdutide: First Approval
1个月前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
1个月前
已完结
Obesity drugs made in China could power next wave of treatments
1个月前
已完结
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP‐1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose‐escalation Phase I study
1个月前
已完结
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
3个月前
已完结
Electrocatalytic Oxidation of Methanol over An Electrode with Ni-MOF-74 Catalyst
3个月前
已完结
Simulation study on functional group-modified Ni-MOF-74 for CH4/N2 adsorption separation
3个月前
已完结
皖公网安备34019202002308
